Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Subscriptions

U-BIOPRED/BIOAIR proteins: inflammation or infection?

David L. Hahn, Wilmore Webley
European Respiratory Journal 2022 60: 2200571; DOI: 10.1183/13993003.00571-2022
David L. Hahn
1Intracell Research Group, Dodgeville, WI, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for David L. Hahn
  • For correspondence: dlhahn@wisc.edu
Wilmore Webley
2University of Massachusetts Amherst, Department of Microbiology, Amherst, MA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Extract

We would like to comment on the interesting report by Sparreman Mikus et al. [1] from the U-BIOPRED Group and the BIOAIR Consortium. The study identified 10 plasma proteins associated with severe asthma present in both the discovery (U-BIOPRED) and validation (BIOAIR) cohorts. These proteins included inflammatory cytokines, growth factors and chitinases, and also sphingolipid pathway, complement cascade and mast cell-related proteins. Notably, these associations were reported to be independent of steroid treatment, and unrelated to type-2 inflammation. We note that all these protein categories can be linked to pathogenesis of the infectious agents previously associated with asthma (rhinovirus, respiratory syncytial virus, adenovirus, Mycoplasma pneumoniae, Chlamydia pneumoniae and Chlamydia trachomatis) [2–4].

Abstract

The U-BIOPRED/BIOAIR proteins are associated with host responses to infections https://bit.ly/3lO2S3r

Footnotes

  • Conflict of interest: D.L. Hahn and W. Webley are uncompensated members of the Intracell Research Group (IRG) scientific advisory board. The mission of IRG includes dissemination of evidence for chronic infection in chronic diseases including asthma. Outside the submitted work, W. Webley also reports grant funding from USDA/NIFA, and lecture honoraria from Baystate Medical Center.

  • Received March 17, 2022.
  • Accepted May 19, 2022.
  • Copyright ©The authors 2022. For reproduction rights and permissions contact permissions{at}ersnet.org
https://www.ersjournals.com/user-licence
View Full Text

ERS Members

myERS - ERS members : log in with your myERS username and password.

INDIVIDUALS

Log in Login as an individual user.

Forgot your username or password?

LIBRARY USERS

Log in through your institution

If your library has a subscription, you may already be logged in via your IP address. Otherwise you may be able to log in via one of the following routes.
You may be able to gain access using your login credentials for your institution. Contact your library if you do not have a username and password.
If your organization uses OpenAthens, you can log in using your OpenAthens username and password. To check if your institution is supported, please see this list. Contact your library for more details.
If you think you should have access, please contact your librarian or email journals@ersnet.org

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top
View this article with LENS
Vol 60 Issue 6 Table of Contents
European Respiratory Journal: 60 (6)
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
U-BIOPRED/BIOAIR proteins: inflammation or infection?
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
Citation Tools
U-BIOPRED/BIOAIR proteins: inflammation or infection?
David L. Hahn, Wilmore Webley
European Respiratory Journal Dec 2022, 60 (6) 2200571; DOI: 10.1183/13993003.00571-2022

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
U-BIOPRED/BIOAIR proteins: inflammation or infection?
David L. Hahn, Wilmore Webley
European Respiratory Journal Dec 2022, 60 (6) 2200571; DOI: 10.1183/13993003.00571-2022
Reddit logo Technorati logo Twitter logo Connotea logo Facebook logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
    • Abstract
    • Shareable PDF
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • Reply: Central apnoeas, sympathetic activation and mortality in heart failure
  • Central apnoeas, sympathetic activation and mortality in heart failure
  • Reply: Triple therapy and adverse cardiovascular events in COPD
Show more Correspondence

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2023 by the European Respiratory Society